Otonomy to Present at the Raymond James Life Sciences and MedTech Conference

World News: . []

SAN DIEGO, June 12, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that David A. Weber, Ph.D., president and chief executive officer, will present at the Raymond James Life Sciences and MedTech Conference on Wednesday, June 19, 2019 at 3:00 p.m. ET (12:00 p.m. PT) at the Lotte New York Palace in New York City.

A live audio webcast and replay of the presentation will be available through the page of the company's website ().  

Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière’s disease, hearing loss, and tinnitus. For additional information please visit .

Media Inquiries Spectrum Leticia Diaz Vice President 202.587.2517

Investor InquiriesWestwicke PartnersRobert H. UhlManaging Director858.356.5932

More news and information about Otonomy, Inc.

Published By:

Globe Newswire: 13:00 GMT Wednesday 12th June 2019

Published: .

Search for other references to "otonomy" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us